Mutations in CDKN2C (p18) and CDKN2D (p19) may cause sporadic parathyroid adenoma

Endocrine-Related Cancer

Volumn 20, Issue 6, 2013, Pages

  Gluick, Thomas ^a   Yuan, Ziqiang ^b   Libutti, Steven K ^b   Marx, Stephen J ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2C; CYCLIN DEPENDENT KINASE INHIBITOR 2D;

CARCINOGENESIS; FRAMESHIFT MUTATION; GENE MUTATION; HUMAN; HYPERPARATHYROIDISM; LETTER; MISSENSE MUTATION; MULTIPLE ENDOCRINE NEOPLASIA; PARATHYROID ADENOMA; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION;

ADENOMA; CYCLIN-DEPENDENT KINASE INHIBITOR P18; CYCLIN-DEPENDENT KINASE INHIBITOR P19; HUMANS; MUTATION; PARATHYROID NEOPLASMS;

EID: 84891378074     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-13-0445     Document Type: Letter

References (13)

1. Agarwal SK, Mateo CM & Marx SJ 2009 Rare germline mutations in cyclindependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states. Journal of Clinical Endocrinology and Metabolism 94 1826-1834. (doi:10.1210/jc.2008-2083)
2. Baumgartner R, Fernandez-Catalan C, Winoto A, Huber R, Engh RA & Holak TA 1998 Structure of human cyclin-dependent kinase inhibitor p19INK4d: comparison to known ankyrin-repeat-containing structures and implications for the dysfunction of tumor suppressor p16INK4a. Structure 6 1279-1290. (doi:10.1016/S0969-2126(98)00128-2)
3. Costa-Guda J, Soong C-P, Parekh VI, Agarwal SK & Arnold A 2013 Germline and somatic mutations in cyclin-dependent kinase inhibitor genes CDKN1A, CDKN2B, CDKN2C in sporadic parathyroid adenomas. Hormones & Cancer 4 301-307. (doi:10.1007/s12672-013-0147-9)
4. CromerMK, Starker LF, Choi M, Udelsman R, Nelson-Williams C, Lifton RP & Carling T 2012 Identification of somatic mutations in parathyroid tumors using whole-exome sequencing. Journal of Clinical Endocrinology and Metabolism 97 E1774-E1781. (doi:10.1210/jc.2012-1743)
5. Guo Y, Mahajan A, Yuan C, Joo SH, Weghorst CM, Tsai M-D & Li J 2009 Comparisons of the conformational stability of the cyclin-dependent kinase (CDK) 4-interacting ankyrin repeat (AR) proteins. Biochemistry 48 4050-4062. (doi:10.1021/bi802247p)
6. Li J, Mahajan A & Tsai MD 2006 Ankyrin repeat: a unique motif mediating protein-protein interactions. Biochemistry 45 15168-15178. (doi:10.1021/bi062188q)
7. Li J, Poi MJ & Tsai MD 2011 Regulatory mechanisms of tumor suppressor P16(INK4A) and their relevance to cancer. Biochemistry 50 5566-5582. (doi:10.1021/bi200642e)
8. Marx SJ 2011 Hyperparathyroid genes: sequences reveal answers and questions. Endocrine Practice17(Suppl 3)18-27. (doi:10.4158/EP11067.RA)
9. Newey PJ, NesbitMA, Rimmer AJ, AttarM,Head RT, Christie PT, Gorvin CM, StechmanM, Gregory L,Mihai R et al. 2012Whole-exome sequencing studies of nonhereditary (sporadic) parathyroid adenomas. Journal of Clinical Endocrinology and Metabolism 97 E1995-E2005. (doi:10.1210/ jc.2012-2303)
10. Pavletich NP 1999 Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors. Journal of Molecular Biology 287 821-828. (doi:10.1006/jmbi.1999.2640)
11. Pellegata NS, Quintanilla-Martinez L, Siggelkow H, Samson E, Bink K, Hofler H, Fend F, Graw J & Atkinson MJ 2006 Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. PNAS 103 15558-15563. (doi:10.1073/pnas.0603877103)
12. Solomon DA, Kim JS, Jenkins S, Ressom H, Huang M, Coppa N, Mabanta L, Bigner D, Yan H, Jean W et al. 2008 Identification of p18 INK4c as a tumor suppressor gene in glioblastoma multiforme. Cancer Research 68 2564-2569. (doi:10.1158/0008-5472.CAN-07-6388)
13. van Veelen W, Klompmaker R, Gloerich M, van Gasteren CJ, Kalkhoven E, Berger R, Lips CJ, Medema RH, Hoppener JW & Acton DS 2009 P18 is a tumor suppressor gene involved in human medullary thyroid carcinoma and pheochromocytoma development. International Journal of Cancer 124 339-345. (doi:10.1002/ijc.23977)